Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA-Protein Vaccination Strategy Does Not Protect from Challenge with African Swine Fever Virus Armenia 2007 Strain

28 Jan 2019

Abstract excerpt

), for which there is no commercially available vaccine. Recent outbreaks of the virus in Trans-Caucasus countries, Eastern Europe, Belgium and China highlight the urgent need to develop effective vaccines against ASFV. Previously, we evaluated the immunogenicity of a vaccination strategy designed to test various combinations of ASFV antigens encoded by DNA plasmids and recombinant proteins with the aim to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Animal Disease Management and Epidemiology
Share to Vector-Borne Animal Diseases
Share to Viral Infections and Immunology Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 30696015
DOI: 10.3390/vaccines7010012

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA-Protein Vaccination Strategy Does Not Protect from Challenge with African Swine Fever Virus Armenia 2007 StrainPMID 30696015Read ↗

Evaluation of a viral DNA-protein immunization strategy against African swine fever in domestic pigsSemantic proximity Read ↗

Subunit Vaccine Approaches for African Swine Fever VirusSemantic proximity Read ↗

Current status and evolving approaches to African swine fever vaccine developmentSemantic proximity Read ↗

Viral Vector Vaccines Against ASF: Problems and ProspectivesSemantic proximity Read ↗

Approaches and Perspectives for Development of African Swine Fever Virus VaccinesSemantic proximity Read ↗

Development and efficacy of a novel mRNA cocktail for the delivery of African swine fever virus antigens and induction of immune responsesSemantic proximity Read ↗

Thoughts on the research of African swine fever live-attenuated vaccinesSemantic proximity Read ↗

A Pool of Eight Virally Vectored African Swine Fever Antigens Protect Pigs against Fatal DiseaseSemantic proximity Read ↗

The Presence of Virus Neutralizing Antibodies Is Highly Associated with Protection against Virulent Challenge in Domestic Pigs Immunized with ASFV live Attenuated Vaccine CandidatesSemantic proximity Read ↗

Design of a Multiepitope Pan‐Proteomic mRNA Vaccine Construct Against African Swine Fever Virus: A Reverse Vaccinology ApproachSemantic proximity Read ↗

Humoral Immune Responses to the Live-Attenuated African Swine Fever Vaccine Candidate VNUA-ASFV-LAV2 Reveal Serological Markers for Vaccine Monitoring and DIVA SurveillanceSemantic proximity Read ↗

An attenuated African swine fever virus expressing the E2 glycoprotein of classical swine fever virus protects pigs against challenge of both virusesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.